Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
• an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women.
• fulvestrant in women with disease progression following endocrine therapy.
Product Name : Palbonix
Generic Name : Palbociclib
Available Pack Size: 21’s Pot
Available Strengths: 125mg
Categories: Anti-viral, Biotech Products, Drugs to treat Hepatitis
Manufacturer: Beacon Pharmaceuticals Ltd.